Evidence map›Paper›PMID 34009551›Full record

ReviewTherapeutic innovation & regulatory science2021

Innovation Pathways in the NHS: An Introductory Review.

Anmol Arora, Andrew Wright, Tsz Kin Mark Cheng, Zahra Khwaja, Matthew Seah

Abstract readReview
In one paragraph

Review in Therapeutic innovation & regulatory science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Integrating Health and Social Care Services.Global advances in health and medicine · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anmol Arora *School of Clinical Medicine, University of Cambridge, Addenbrooke's Hospital, Cambridge, CB2 0SP, UK. aa957@cam.ac.uk.ORCID http://orcid.org/0000-0003-4881-8293
Andrew Wright *Department of Physiology, Development and Neuroscience, University of Cambridge, Cambridge, UK.
Tsz Kin Mark ChengDepartment of Medical Sciences, Faculty of Biology, University of Cambridge, Cambridge, UK.ORCID https://orcid.org/0000-0003-4323-5574
Zahra KhwajaDepartment of Pathology, University of Cambridge, Cambridge, UK.
Matthew SeahDepartment of Surgery, University of Cambridge, Cambridge, UK.ORCID http://orcid.org/0000-0002-5850-125X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Healthcare as an industry is recognised as one of the most innovative. Despite heavy regulation, there is substantial scope for new technologies and care models to not only boost patient outcomes but to do so at reduced cost to healthcare systems and consumers. Promoting innovation within national health systems such as the National Health Service (NHS) in the United Kingdom (UK) has been set as a key target for health care professionals and policy makers. However, while the UK has a world-class biomedical research industry, several reports in the last twenty years have highlighted the difficulties faced by the NHS in encouraging and adopting innovations, with the journey from idea to implementation of health technology often taking years and being very expensive, with a high failure rate. This has led to the establishment of several innovation pathways within and around the NHS, to encourage the invention, development and implementation of cost-effective technologies that improve health care delivery. These pathways span local, regional and national health infrastructure. They operate at different stages of the innovation pipeline, with their scope and work defined by location, technology area or industry sector, based on the specific problem identified when they were set up. In this introductory review, we outline each of the major innovation pathways operating at local, regional and national levels across the NHS, including their history, governance, operating procedures and areas of expertise. The extent to which innovation pathways address current challenges faced by innovators is discussed, as well as areas for improvement and future study.

Indexed as

Delivery of Health CareState MedicineBiomedical TechnologyHumansInventionsUnited KingdomEntrepreneurshipInvestmentQualitySafetyTechnology

Identifiers

PMID34009551
PMCPMC8132486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.